Glucagon-like Peptide-2 (GLP-2) Agonists [MoA] - N0000190990
Pharmacologic Class Information
| Pharmacologic Code | N0000190990 |
| Pharmacologic Name | Glucagon-like Peptide-2 (GLP-2) Agonists |
| Pharmacologic Uses |
|
| Pharmacologic Concept | Mechanisms of Action - [MoA] |
| Pharmacologic Concept Description | This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept. |
NDC Products with Glucagon-like Peptide-2 (GLP-2) Agonists
The table contains 1 products whose active ingredient are classified under the same pharmacologic class Glucagon-like Peptide-2 (GLP-2) Agonists [MoA].
| NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Status | |
|---|---|---|---|---|---|---|---|
| 68875-0101 | Gattex | Non-Proprietary Name: Teduglutide | Injection, Powder, Lyophilized, For Solution | Subcutaneous | Takeda Pharmaceuticals America, Inc. | ACTIVE |